AboutTeamPortfolioInsights

Biopharmaceutical company focused on microRNA (miRNA)-directed oncology therapies

Sectors
Healthcare
Life Sciences
First Invested
2012
Early
Company Status
IPO/Public
NASDAQ: MIRN
Associated Team
Ali Behbahani, MD
Edward Mathers
Website
Mirna Therapeutics